ImageneBio (IMA) Research & Development (2020 - 2025)

ImageneBio has disclosed Research & Development across 6 years of filings, most recently posting $15.6 million for Q3 2025.

• Research & Development for Q3 2025 came in at $15.6 million, up 300.46% year-over-year; the trailing twelve-month figure through Sep 2025 was $26.1 million (down 37.73% YoY), and the FY2024 annual result was $30.9 million, down 48.24% from the prior year.
• Research & Development came in at $15.6 million for Q3 2025 at ImageneBio, up from $4.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $18.8 million in Q3 2022 to a low of $2.5 million in Q4 2024.
• The 5-year median for Research & Development is $14.0 million (2024), against an average of $11.8 million.
• Across the five-year window, Research & Development plunged 82.31% in 2024 and jumped 300.46% in 2025, its largest moves.
• ImageneBio's Research & Development stood at $12.3 million in 2021, then advanced by 26.75% to $15.6 million in 2022, then fell by 8.73% to $14.3 million in 2023, then sank by 82.31% to $2.5 million in 2024, then soared by 516.16% to $15.6 million in 2025.
• The last three Research & Development figures came in at $15.6 million (Q3 2025), $4.0 million (Q2 2025), and $4.0 million (Q1 2025), per Business Quant data.